Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12377115
Combination immunotherapies for treatment of cancer
granted -
US 12378193
Anti-arrhythmicity agents
granted -
US 12377106
Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and for degrading BTK
granted -
US 12377101
Combination therapies
granted -
US 12378241
Pyridine derivative as FGFR and VEGFR dual inhibitors
granted -
US 12377104
Methods for treating a fatty liver disease
granted -
US 12377102
Compounds for the prevention and treatment of medical disorders and uses thereof
granted -
US 12378337
Lipid nanodiscs solubilized through poly(acrylic acid-co-styrene) copolymers
granted -
US 12377096
Methods of treating disease with levoketoconazole
granted -
US 12378286
Methods and compositions useful for inhibiting growth of certain bacteria
granted -
US 12377036
Melanin hair dye with thickeners
granted -
US 12377112
Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
granted -
US 12378560
Sequence multiplicity within spherical nucleic acids
granted -
US 12377078
Viral inhibitors, the synthesis thereof, and intermediates thereto
granted -
US 12377051
Microspheres for extended, controlled release of therapeutic agents
granted -
US 12377082
Nicorandil derivatives
granted -
US 12378540
Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof
granted -
US 12378557
Treatment of sepsis with PCSK9 and LDLR modulators
granted -
US 12378558
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of use
granted -
MX 2025007399
PROTEIN-BASED CONJUGATION CARRIERS
granted -
CN 120418289
Combination therapy of bispecific binding agents that bind to CLDN18.2 and CD3 with immune checkpoint inhibitors
granted -
WO 2025159142
COMPOSÉ HÉTÉROCYCLIQUE POUR INDUIRE LA DÉGRADATION DE LA PROTÉINE KRAS
granted -
US 12371445
Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
granted -
US 12371466
Chimeric antigen receptor and methods of use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.